Reaction
Gastrointestinal Mucormycosis reporting signals
As of the last recalculation, Gastrointestinal Mucormycosis appears in 157 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is MICAFUNGIN SODIUM (PRR 298.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Micafungin Sodium | 17 | 298.0 | 298.6 |
| Ganciclovir | 11 | 153.1 | 153.3 |
| Ganciclovir Sodium | 11 | 148.1 | 148.3 |
| Basiliximab | 12 | 146.4 | 146.5 |
| Amphotericin B | 12 | 137.4 | 137.5 |
| Piperacillin And Tazobactam | 11 | 122.5 | 122.6 |
| Valganciclovir Hydrochloride Powder, | 10 | 116.0 | 116.1 |
| Mycophenilic Acid | 16 | 113.9 | 113.9 |
| Voriconazole Injection | 15 | 101.1 | 101.2 |
| Cladribine | 7 | 101.0 | 101.1 |
| Valganciclovir | 13 | 99.6 | 99.6 |
| Valganciclovir Hydrochloride | 13 | 99.6 | 99.6 |
| Posaconazole Delayed-Release | 7 | 88.4 | 88.5 |
| Posaconazole | 9 | 77.8 | 77.9 |
| Remdesivir | 7 | 72.8 | 72.9 |
| Thiotepa | 5 | 71.7 | 71.7 |
| Oseltamivir | 4 | 68.3 | 68.3 |
| Brentuximab Vedotin | 4 | 53.1 | 53.1 |